In 2023, Eli Lilly entered the market with Zepbound (tirzepatide), boasting over 20% weight loss at 72 weeks and a slightly lower price
They may order laboratory tests to evaluate electrolyte balance, kidney function, and hydration status, particularly in high-risk patients such as older adults or those with kidney disease
Just maybe, there might be a greater incentive for primary care doctors to diagnose sooner and insurance companies to support to cover early diagnostics for patients at great risk of PAD, especially diabetics
These are controlled-trial averages in a specific study population: they are not guaranteed outcomes and individual results vary based on adherence, dose achieved, and individual metabolic response
Also detoxifies the liver, kidneys and lymphatic system